ESCMID Global is the annual congress of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) (formerly ECCMID).
The European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global Annual Meeting 2026 will take place in Munich, Germany, between April 17 and 21.
In advance of the confernece, The analyst highlighted highly anticipated and noteworthy abstracts in this Pre-Conference Coverage report.
The European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global Annual Meeting 2026 will take place in Munich, Germany, between April 17 and 21.
In advance of the confernece, The analyst highlighted highly anticipated and noteworthy abstracts in this Pre-Conference Coverage report.
Report Scope
Indications, companies, and therapies discussed:
RSV
- Enanta Pharmaceuticals - Zelicapavir
Chikungunya virus
- Evotec - EVT894
Influenza
- Moderna - mRNA-1010
- Shionogi - Secutrelvir
HSV
- AICuris - Pritelivir
- Innovative Moleules - Adibelivir
Hepatitis B
- Helmholtz-Zentrum fur Umweltforschung - TherVacB
Complicated urinary tract infections/axute pyelonephritis
- Wockhardt - Zaynich
Invasive fungal infections
- F2G - Olorofim
- Scynexis - SCY-247
Reasons to Buy
- This powerpoint-based deliverable highlights noteworthy conference abstracts, and the potential implications for your strategy, covering disease areas such as RSV, influenza, COVID-19, HSV, UTIs, fungal infections, and more.
Table of Contents
1. Introduction1.1. Contents
1.2. Abbreviations
2. Key Presentations
3. Appendix
3.1. About the Authors
3.2. Contact the Publisher
3.3. About the Analyst
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Enanta Pharmaceuticals
- Evotec
- Moderna
- Shionogi
- AICuris
- Innovative Molecules
- Helmholtz-Zentrum fur Umweltforschung
- Wockhardt
- F2G
- Scynexis
